Avexa News
Most Popular Avexa Story
Avexa woos investors with late-stage prospects
Australia's Avexa has been wooing investors recently over the prospects of its late-stage HIV therapy, and the added attention has paid off with a spike in its stock price. Avexa shares jumped 23 Read more...
Latest Headlines
- May 10, 2010
- October 14, 2009
- March 10, 2009
- January 7, 2009
- December 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
